PaulGRubinsteinMD

Oncology • Chicago, IL

Hematologic Oncology

Physician

Join to view full profile

Dr. Rubinstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rubinstein's full profile

Already have an account?

Office
840 S Wood St
Suite 820-E Csb (Mc 713
Chicago, IL 60612
Phone+1 312-996-2242
Is this information wrong?

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2006 - 2009
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2003 - 2006
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003

Certifications & Licensure

IL State Medical License 2003 - 2026
American Board of Internal Medicine Hematology

Clinical Trials

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 May 01
Completed
Phase 3
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma Start of enrollment: 2010 May 01
Completed
Phase 2
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma Start of enrollment: 2013 Mar 07
Active, not recruiting
Phase 1, Phase 2
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Start of enrollment: 2015 Oct 21
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
Ayana E Morales, Ruby Gumenick, Caitlyn M Genovese, Yun Yeong Jang, Ariene Ouedraogo, Maite Ibáñez de Garayo, Tania Pannellini, Sanjay Patel, Matthew E Bott, Julio Alv...> ;Plos Pathogens. 2024 Jan 1
1 citations
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
Lakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, Shelly Lensing, Jeannette Lee, Juan Carlos Ramos, Robert Baiocchi, Lee Ratner, Paul G Rubinstein, Richard Ambin...> ;Cancer. 2024 Mar 15
4 citations
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
Zayac, A., Landsburg, D., Hughes, M., Bock, A., Nowakowski, G., Ayers, E., Girton, M., Hu, M., Beckman, A., Li, S., Medeiros, L., Chang, J., Stepanovic, A., Kurt, H., ...> ;Blood Advances. 2023 Nov 14
2 citations
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
Paul G Rubinstein, Page C Moore, Milan Bimali, Jeanette Y Lee, Michelle A Rudek, Amy Chadburn, Lee Ratner, David H Henry, Ethel Cesarman, Camille E DeMarco, Dominique ...> ;The Lancet. Haematology. 2023 Aug 1
7 citations
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in Pe...
Dobbs, R. W., Talal El Zarif, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingji...> ;Journal of Clinical Oncology. 2023 Jul 20
20 citations
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.
Thomas, N., Dreval, K., Gerhard, D., Hilton, L., Abramson, J., Ambinder, R., Barta, S., Bartlett, N., Bethony, J., Bhatia, K., Bowen, J., Bryan, A., Cesarman, E., Casp...> ;Blood. 2023 Feb 23
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study.
Missak Haigentz, Page Moore, Milan Bimali, Joseph Sparano, Michelle Rudek, Lee Ratner, David Henry, Juan Ramos, John Deeken, Paul Rubinstein, Elizabeth Chiao, Timothy ...> ;The Oncologist. 2022 Aug 5
Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma.
Parag Mahale, Jason Nomburg, Joo Y. Song, Mia Steinberg, Gabriel J. Starrett, Joseph Boland, Charles F. Lynch, Amy Chadburn, Paul G. Rubinstein, Brenda Y. Hernandez, D...> ;Infectious Agents and Cancer. 2021 Nov 14
39 citations
KSHV/HHV8-mediated hematologic diseases.
Ethel Cesarman, Amy Chadburn, Paul G. Rubinstein> ;Blood. 2021 Sep 3
28 citations
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
Juan Carlos Ramos, Joseph A. Sparano, Amy Chadburn, Erin Reid, Richard F. Ambinder, Eric R. Siegel, Page C. Moore, Paul G. Rubinstein, Christine M. Durand, Ethel Cesar...> ;Blood. 2020 Sep 10
4 citations
Pernicious Anemia Presenting With Pseudo Thrombotic Microangiopathy and Falsely Elevated B 12 Levels.
Vatsala Katiyar, Edward Qian, Ishaan Vohra, Jose Sleiman, Paul G. Rubinstein> ;Journal of Hematology. 2019 Sep 30
16 citations
Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.
Paul G. Rubinstein, Page C. Moore, Michelle A. Rudek, David H. Henry, Juan Carlos Ramos, Lee Ratner, Erin Reid, Elad Sharon, Ariela Noy> ;AIDS. 2017 Dec 1
32 citations
Long-term survival in AIDS-related primary central nervous system lymphoma.
Neel K. Gupta, Amber Nolan, Antonio Omuro, Erin Reid, Chia-Ching Wang, Gabriel N. Mannis, Michael Jaglal, Julio C. Chavez, Paul G. Rubinstein, Ann Griffin, Donald I. A...> ;Neuro-Oncology. 2017 Jan 1
8 citations
Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura A Case Series
Paul G. Rubinstein, David M. Aboulafia> ;Journal of the International Association of Providers of AIDS Care. 2015 May 1
224 citations
Flow Sorting and Exome Sequencing Reveal the Oncogenome of Primary Hodgkin and Reed-Sternberg Cells
Jonathan Reichel, Amy Chadburn, Paul G. Rubinstein, Lisa Giulino-Roth, Wayne Tam, Yifang Liu, Rafael Dezen Gaiolla, Kenneth Eng, Joshua Brody, Giorgio Inghirami, Carme...> ;Blood. 2015 Feb 12
153 citations
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
Paul G. Rubinstein, David M. Aboulafia, Andrew Zloza> ;AIDS. 2014 Feb 20
3 citations
Thalidomide-Associated Thrombosis in the Treatment of HIV-Associated Severe Aphthous Disease: A Case Report and Review of the Literature
Aimee C. Hodowanec, Alice Han, David E. Barker, Paul G. Rubinstein, Blake Max> ;Journal of the International Association of Physicians in AIDS Care. 2012 Aug 27
4 citations
Durable Complete Remission Induced by Cetuximab Monotherapy in a Patient Infected With HIV and Diagnosed With Recurrent Squamous Cell Carcinoma of the Head and Neck
Paul G. Rubinstein, Valerie Lindgren, Suman Setty, Mike Yao, Kristen B. Pytynia, James A. Radosevich, Shrihari S. Kadkol, Lawrence Eric Feldman> ;Journal of Clinical Oncology. 2011 Mar 20
Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
Paul Rubinstein, Yi‐Hsiang Chen> ;American Journal of Hematology. 2008 Aug 1
Join now to see all

Abstracts/Posters

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatm...
Paul G. Rubinstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Characteristics, Social Factors, and Trends in HIV and AIDS-Related Lymphoma: A 23-Year Analysis Since the Implementation of c ART, a County Hospital AIDS Malignancy P...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018